Home About Us Contact Us

 

Table of Content - Volume 20 Issue 1 - October 2021


 

A comparative study of dexmedetomidine versus clonidine to attenuate the hemodynamic response to laryngoscopy and endotracheal intubation

 

Sachin Madhukar Kumbhar*, V V Kulkarni, Shrikrishn Kamat

                   

Department of Anaesthesiology, Dr V M Government Medical College, Solapur, Maharashtra, INDIA.

Email: skumbhar36@gmail.com

 

Abstract              Background: General anaesthesia is gold standard and carried out with laryngoscopy and endotracheal intubation. Laryngoscopy and endotracheal intubation are associated with critical events because it accentuates significant sympatho-adrenal response in the form of tachycardia and hypertension. This study was carried out to compare the effect of single dose of clonidine and dexmedetomidine to suppress pressor response to laryngoscopy and endotracheal intubation. Material and Methods: Present study was prospective double blind randomized single center clinical study, conducted in patients of age group 18-60 years belonging to ASA status I/II, MPG I/II, who was posted for elective surgery under GA, willing to participate in study. Results: The mean age in group I was 36.16 + 9.86 and in group II was 33.83 + 10.22. p value is 0.3725. Females predominated in both groups and are comparable in both groups. General Characteristics such as age (years), Sex (M/F), Weight(kg), ASA (I/II) and Surgeries were comparable in both groups, difference was not statistically significant. In group Dexmedetomidine significant reduction in pulse rate compare to Clonidine group. Also pulse rate compared to base line is significantly reduced in dexmedetomidine group. In group Dexmedetomidine significant reduction in systolic blood pressure compare to Clonidine group. Also changes in systolic blood pressure compared to base line was significantly reduced in dexmedetomidine group. Ramsey sedation score after 3 min end of test dose was statistically significant in Dexmedetomidine group as compared to clonidine group. The mean dose of thiopentone sodium (mg) required for loss of eye lash reflex in group I and Group II were 302.5±56.22 and 355.8±82.96 respectively and it was statistically highly significant decrease in dose of thiopentone sodium required for induction in dexmedetomidine group. Intraoperative (bradycardia) and post-operative complication (Post op nausea and vomiting and dryness of mouth) were observed in both groups, which was statistically not significant. Conclusion: Dexmedetomidine is better in position when compared to clonidine for attenuation of pressor response to laryngoscopy and endotracheal intubation and also decreases requirement of thiopentone sodium for induction of general anaesthesia

Keywords: Dexmedetomidine, clonidine, attenuation of pressor response, general anaesthesia.

 

INTRODUCTION

General anaesthesia is gold standard and carried out with laryngoscopy and endotracheal intubation. Laryngoscopy and endotracheal intubation are associated with critical events because it accentuates significant sympatho-adrenal response in the form of tachycardia and hypertension. These responses can be detrimental in elderly and hemodynamically compromised patients due to increase in arterial pressure, heart rate and oxygen consumption. Therefore controlling this perioperative stress response is an important goal of modern anaesthesia.1,2,3 Many pharmacological methods were evaluated either in premedication or during induction to attenuate these adverse hemodynamic responses but the drugs which were used where either partially effective or they produced other undesirable effects. Dexmedetomidine is more potent α-2 receptor agonist when compared to clonidine. So, Dexmedetomidine is better drug of choice among α-2 receptor agonist to suppress deleterious hemodynamic response to laryngoscopy and endotracheal intubation.4 Though Dexmedetomidine is costly compared to clonidine, it significantly reduces drug requirement of anaesthetic agent with better haemodynamic blunting response to laryngoscopy and intubation.5 Various Studies are done with different doses of Dexmedetomidine and Clonidine.4,6 Sagiroglu et al.,6 conducted study with different doses of dexmedetomidine to control hemodynamic responses to intubation and he found that dexmedetomidine 1 μg /kg is more effective than 0.5 μg/kg without any side effects. The effects of clonidine on the hemodynamic variables are dose related but this dose of Clonidine (1 μg /kg) was consider appropriate to provide adequate clinical effects.7 This study was carried out to compare the effect of single dose of clonidine and dexmedetomidine to suppress pressor response to laryngoscopy and endotracheal intubation.

              

MATERIAL AND METHODS

Present study was prospective double blind randomized single centre clinical study, conducted in Department of Anaesthesiology, Dr V M Government Medical College, Solapur, India. Study duration was of 2 years (July 2018 to June 2019). Study was approved by institutional ethical committee.

Inclusion criteria: patients of age group 18-60 years belonging to ASA status I/II, MPG I/II, who was posted for elective surgery under GA, willing to participate in study.

Exclusion criteria: ASA grade III, IV and V. Age More than 60 years. Patient on anti-hypertensive. Patient with difficult airway.

Written informed consent of the patient has been taken after explaining the anaesthesia technique. Patient under the study was undergone through preanesthetic evaluation including detailed history, clinical examination and necessary investigation depending on ages, sex, disease of patient. Pre-operative, Xylocaine sensitivity test (XST) was done and patients were kept nil per oral for 6 hrs. before surgery

In present study, 60 patients were selected and were randomly divided into two groups.

  • Group-1 Dexmedetomidine 1 Mcg /Kg diluted up to 10 cc over 10 min.
  • Group-2 Clonidine 1 Mcg/Kg. diluted up to 10 cc over 10 min.

On arrival in the anaesthetic room, heart rate, oxygen saturation and non-invasive blood pressure monitoring will be instituted. Premedication: All patients of both Groups were premedicated with Inj. Ranitidine 1 mg/kg and Inj. Metoclopramide 0.2mg/kg body weight intravenously. Inj. Glycopyrrolate 0.004mg/kg body weight were given intravenously 20 minutes before IV premedication. All patients were preoxygenated with 100% oxygen for 5 minutes. prior to induction.

Anaesthesia were induced with Inj. Thiopentone till loss of eyelash reflex. Succinylcholine 2mg/kg body weight were given for relaxation. Patient were intubated with appropriate size cuffed endotracheal tube. Anaesthesia were maintained on 02(50%), N20(50%) and Isoflurane (0.5-1%). Any intraoperative complications such as hypotension, bradycardia, Airway obstruction, Regurgitation and Laryngospasm or postoperative complications such as delayed recovery, Hoarseness of voice and sore throat, hypotension, bradycardia if occurred were noted. After surgery, neuromuscular block was antagonized with neostigmine (0.05 mg/kg) and glycopyrrolate (0.01 mg/kg). and extubated after deflating the cuff when the patient regained consciousness and protective airway reflexes. All the above recorded observations were compared statistically and the results were analysed and concluded. Quantitative data was analyzed by student ‘t’ test and qualitative data was

 

RESULTS

The mean age in group I was 36.16 + 9.86 and in group II was 33.83 + 10.22. p value is 0.3725. Females predominated in both groups and are comparable in both groups. General Characteristics such as age (years), Sex (M/F), Weight(kg), ASA (I/II) and Surgeries were comparable in both groups, difference was not statistically significant.


 

Table 1: General Characteristics

Characteristics

Group I

Group II

P-value

Age (years)

36.16 ± 9.86

33.83 ± 10.22

0.0786

Sex (M/F)

8/22

13/17

0.1770

Weight(kg)

53.2 ± 6.82

54.5 ± 6.63

0.3308

ASA (I/II)

24/6

26/4

 

Surgeries

 

 

 

Fibroadenoma Excision

3 (10 %)

4 (13.33%)

 

Lipoma Excision

2 (6.66%)

2 (6.66%)

 

cholecystectomy

6 (20 %)

4 (13.33%)

 

laminectomy

4 (13.33%)

3 (10 %)

 

FESS

4 (13.33%)

4 (13.33%)

 

mastoidectomy

4 (13.33%)

4 (13.33%)

 

LAVH

2 (6.66%)

2 (6.66%)

 

thyroidectomy

2 (6.66%)

4 (13.33%)

 

Parotid excision

1 (3.33%)

1 (3.33%)

 

MRM

2 (6.66%)

2 (6.66%)

 

Mean pulse rates in both groups at baseline before test dose, after 3 min test dose, after induction, during intubation, after intubation 1min,3min,5min,10min wear recorded. In group Dexmedetomidine significant reduction in pulse rate compare to Clonidine group. Also pulse rate compared to base line is significantly reduced in dexmedetomidine group.

 

Table 2: comparison of Changes in PR at Various Term Periods

 

 

Time

Group I

Group II

P-

Value

Mean ±SD

% Change from baseline

Mean ±

SD

% Change from baseline

Basal

79.93+8.09

-

81.86±9.91

-

0.409

After study drug

76.1+7.29

↓4.79

81.96+8.50

↑0.12

0.001

At induction

73.2+6.95

↓8.41

87.1+8.51

↑6.01

0.001

At intubation

74.53+6.16

↓6.75

90.2+8.89

↑9.24

0.001

1 min after intubation

72.33+6.81

↓9.5

86.36+8.75

↑5.2

0.001

3 min. after intubation

71.63+6.69

↓10.38

87.26+8.78

↑6.2

0.001

5min after intubation

70.93+6.48

↓11.25

87.13+841

↑6.04

0.001

10 min after intubation

73.44+4.79

↓8.11

87.81+9.31

↑6.7

0.003

In group Dexmedetomidine significant reduction in systolic blood pressure compare to Clonidine group. Also changes in systolic blood pressure compared to base line was significantly reduced in dexmedetomidine group.

 

Table 3: Comparison of changes in systolic blood pressure (SBP)

 

 

Time

Group I

Group II

P-Value

Mean ±SD

% Change

from baseline

 

Mean ± SD

%Change

from baseline

 

Basal

122.73+11.11

-

121.06+8.56

-

0.516

After test dose 3 min

114.13+10.30

↓7.0

129.4+8.94

↑5.1

0.0001

At induction

112.26+9.37

↓8.5

130.2+8.12

↑5.7

0.0001

At intubation

133.1 ±0.9132

↑7.79

140.3 ±1.283

↑13.52.

<0.001

1 min after intubation

111.06+9.19

↓9.50

130.2+8.12

↑7.01

0.0001

3 min. after intubation

109.72+8.25

↓10.60

130.53+6.94

↑7.25

0.0001

5min after intubation

108.66+8.36

↓12.94

130.5+7.98

↑7.2

0.0001

10 min after intubation

109+1.41

↓11.18

128.6+8.08

↓5.8

0.0001

In group Dexmedetomidine significant reduction in diastolic blood pressure compare to Clonidine group. Diastolic blood pressure compared to base line was significantly reduced in dexmedetomidine group.

 

Table 4: Comparison of changes in mean diastolic blood pressure (DBP)

 

Time

Group I

Group II

P-Value

Mean ±SD

% Change from

baseline

Mean ± SD

% Change from

baseline

 

Basal

78.06±6.65

-

75.26±5.23

-

0.075

After 3 min test dose

73.8±6.75

↓5.4

80.66±6.11

6.6

0.0001

At induction

71.2±6.86

↓8.78

82.8±6.48

9.10

0.001

At intubation

73.33±4.61

↓6.05

86.033±5.48

↑12.51

0.0001

1 min after Intubation

69.2±5.47

↓11.3

83.33±1.306

↑9.68

0.0001

3 min. after intubation

69.06±6.57

↓11.5

83.33±5.31

↑9.68

<0.0001

5min after intubation

68.96±5.77

↓11.65

84.13±4.03

↑10.54

<0.0001

10 min after intubation

70.22±4.52

↓9.97

84.37±3.36

↑10.7

<0.0001

In group Dexmedetomidine group significant reduction in mean arterial pressure compare to Clonidine group. Also percent changes in mean arterial pressure compared to base line was significantly reduced in dexmedetomidine group.

 

Table 5: Changes in MAP at Various Term Periods

Time

Group I

Group II

P-

Value

Mean

±SD

% Change from baseline

Mean ± SD

% Change from baseline

Basal

92.95 ± 7.87

-

90.53 ± 5.96

-

0.075

After 3 min test dose

88.55 ± 7.482

↓4.7

95.99 ± 6.994

5.68

0.0001

At induction

88.55± 7.48

↓4.7

96±6.99

5.69

0.001

At intubation

89.54 ± 5.070

↓3.6

101.60 ±6.032

↑10.89

0.0001

1 min after intubation

85.73±7.54

↓7.76

98.33 ± 7.002

↑7.93

0.0001

3 min. after intubation

85.73±7.54

↓7.76

98.95 ± 5.88

↑8.5

<0.0001

5min after intubation

83.06±7.11

↓10.64

98.95 ± 5.88

↑8.5

<0.0001

10 min after intubation

82.55±6.26

↓11.18

99.6 ± 4.63

↑9.1

<0.0001

Ramsey sedation score after 3 min end of test dose was statistically significant in Dexmedetomidine group as compared to clonidine group. The mean dose of thiopentone sodium (mg) required for loss of eye lash reflex in group I and Group II were 302.5±56.22 and 355.8±82.96 respectively and it was statistically highly significant decrease in dose of thiopentone sodium required for induction in dexmedetomidine group. Intraoperative (bradycardia) and post-operative complication (Post op nausea and vomiting and dryness of mouth) were observed in both groups, which was statistically not significant.

Table 5: other characteristics

 

Group I

Group II

P value

Ramsey sedation score after 3 min end of test dose

2.866+0.7302

2.366+0.85028

0.0176

Total Dose of Inj. Thiopentone (2.5%)

302.5±56.22

355.83±82.96

.0051

intra operative Complications - Bradycardia

1

0

-

Post-operative Complications

 

 

 

PONV

3

4

-

Dryness of mouth

1

1

-

 


DISCUSSION

Two predictors of perioperative cardiac morbidity are increase in heart rate and blood pressure. Increase in heart rate and acute hypertension deleteriously affect myocardial oxygen supply and demand. Different techniques are being tried to prevent or attenuate the hemodynamic effects following laryngoscopy and tracheal intubation, like deepening of anaesthesia, avoiding anticholinergic drugs prior to surgery, pre-treatment with lignocaine, vasodilators like nitroglycerin, beta blockers, calcium channel blockers and opioids. Baseline pulse rate in both groups were comparable and there was no statistically difference. Baseline pulse rate as group I and group II were 79.93+8.09 and 81.85+9.91 respectively. Similar to our study Bijoy Kumar et al.,4 and Shirsendu et al.,8 who have done comparison of clonidine and Dexmedetomidine and have also found fall in HR after its infusion. Scheinin et al.,9 reported that use of α2 agonist leads to bradycardia, not significant with present study. During intubation there was rise in pulse rate in both the groups which was more in Group II compare to Group I and this rise in PR in group II was statistically significant Similar to our result Shrisendu et al.,8 has also found statistically significant rise in PR during intubation in clonidine group compare to dexmedetomidine. In his study this statistically significant higher PR in clonidine group last upto 3 min after intubation.

In our study, after intubation there was statistically significant difference in PR between two groups. Bijoy Kumar et al.,4 in his study found rise in PR after intubation with only clonidine but not with Dexmedetomidine. A biphasic cardiovascular response has been described after the administration of Dexmedetomidine.10 A bolus of 1μg/kg results in a transient increase in arterial blood pressure and reflex increase in heart rate is due to α2 receptor stimulation of vascular smooth muscle. This can be markedly decreased by slow infusion over 10 min. In our study this effect was not noticed due to the slow infusion of the drug over 10 min.11 Similarly to our study Nermin et al.,12 found fall in BP after infusion of Dexmedetomidine and Gupta et al.,7 found fall in BP with Clonidine Shirsendu et al.,8 has also noticed significant rise in SBP in clonidine group almost 14.67% than in Dexmedetomidine where rise in SBP was only 7%. Bijoy Kumar et al.,4 has found comparatively more increase in SBP with Clonidine than Dexmedetomidine. Similar findings were noted in present study. Similar to SBP, DBP had significant rise in Group II in response to intubation compare to Group I. During laryngoscopy and intubation and immediately after it, rise in the HR and Blood pressure was maximum, these findings are in agreement with the studies done by Derbyshire et al.,12 and Shribman et al.,1 who concluded that the plasma catecholamine concentration increased to the maximum within 1 min after intubation. In both groups SBP and DBP started falling immediately after intubation but rate of fall in BP was more gradual in Group II, so Dexmedetomidine was more efficient in the attenuation of rise in MAP compared to Clonidine in response to intubation. Similarly, Scheininet al. et al.,9 has proved that Dexmedetomidine attenuate the cardiovascular response to laryngoscopy and intubation by measuring catecholamine concentration and found that the concentration of noradrenaline in mixed venous plasma was smaller in the Dexmedetomidine group during all phases of induction. In the study done by Bajwa S et al.,14 studied the attenuation of pressor response and dose sparing of opioid and anaesthetic requirement with preoperative administration of dexmedetomidine 1μcg/kg compared with fentanyl 2μcg/kg. They found that mean MAP was significantly lower in group D, 20 minutes after infusion of study drug compared with similar parameter in group F. Ramsay sedation score in Group I was higher than Group II. Shirsendu et al.,8 has also showed statistically higher Ramsay sedation score with Dexmedetomidine than with Clonidine. The major sedative and antinociceptive effects of Dexmedetomidine are attributable to its stimulation of α2 A subtype located in locus ceruleus. It is the 8 times more specificity of Dexmedetomidine for α2 receptor that makes it a more effective sedative and analgesic agent than Clonidine. Even though higher sedation score seen with Dexmedetomidine was not associated with fall in SpO2. Similarly Shirsendu et al.,8 also found no respiratory depression or decrease in SpO2 with similar doses of Dexmedetomidine, so we can conclude that Dexmedetomidine doesn’t cause significant respiratory depression. In clonidine group, no side effects were observed. One patient in group Dexmeditomine had developed bradycardia at 3rd minute after intubation; which was managed by inj. Atropine 0.6 mg. Bajwa S et al.,14 suggested that cardiac side effects of Dexmedetomidine like bradycardia and sinus pause could have warranted the use of atropine. Bijoy Kumar et al.,4 cleared that clonidine and dexmedetomidine does not cause any serious side effect. Use of intraoperative Bi -spectral Index monitoring might have been more precise for the depth of anaesthesia and anaesthetic dose requirement and this might be limitation of our present study.

 

CONCLUSION

Dexmedetomidine is better in position when compared to clonidine for attenuation of pressor response to laryngoscopy and endotracheal intubation and also decreases requirement of thiopentone sodium for induction of general anaesthesia. There were no any significant adverse effects found with intravenous Dexmedetomidine. This technique will definitely add to the safety of anaesthetic management of patients who are at increased risk of harmful effects of stress response during intubation.

 

REFERENCES

  • Shribman AJ, Smith G, Achola J. Cardiovascular and catecholamine responses to laryngoscopy with or without tracheal intubation.Br J Anaesth 1987; 59:295-9.
  • Saif GM, Singh V, Kumar A, Wahal R, Bhatia VK. A study of cardiovascular response during laryngoscopy and intubation and their attenuation by ultra-short acting beta-blocker esmolol.Ind J Anaesth 2002; 46:104-6.
  • Joris JL, Chiche JD, Canivet JL, Jacquet NJ, Legros JJ, Lamy ML. Hemodynamic changes induced by laparoscopy and their endocrine correlates: Effects of clonidine. J Am CollCardiol 1998; 32:1389-96.
  • GerlachAT, Dasta JF. Dexmedetomidine: An updated review. Ann Pharmacother 2007; 41:245-52.
  • Bijoy Kumar Panda, Priyanka Singh, Sourabh Marne, AtmaramPawar, VarshaliKeniya, SushmaLadi, Sarita Swami. A Comparison study of Dexmedetomidine vsClonidine for sympathoadrenal response, perioperative drug requirements and cost analysis. Asian Pacific Journal of Tropical Disease (2012); 1-6.
  • A Sagiroglu, M Celik, Z Orhon, S Yüzer, B Sen. Dıfferent Doses of Dexmedetomidine on Controllıng Haemodynamıc Responses to Tracheal Intubatıon. The Internet Journal of Anesthesiology.2009;27:2.
  • Gupta Kumkum, Lakhanpal Mahima, GuptaPrashant, Krishan Atul, RastogiBhawna, TiwariVaibhav.Premedication with clonidine versus fentanyl for intraoperative hemodynamic stability and recovery outcome during laparoscopic cholecystectomy under general anesthesia. Anesthesia: Essays and Researches2013; 7 (1): 29-33
  • Shirsendu Mondal, Hindol Mondal, Ritaban Sarkar, Musfikur Rahaman. Comparison of dexmedetomidine and clonidine for attenuation of sympathoadrenal responses and anesthetic requirements to laryngoscopy and endotracheal intubation. Int J Basic ClinPharmacol. 2014; 3(3): 501-506
  • Scheinin B, Lindgren L, Randell T, et al.: Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and perioperative fentanyl. Br J Anaesth 1992; 68:126-131.
  • Hulya Basar, Serpil Akpinar; The effects of preanaesthetic, singledose dexmedetomidine on induction, hemodynamic and cardiovascular parameters. Journal of Clinical Anaesthesia 2008; 20:431-436.
  • Sulaiman S, Karthikeyan RB, Vakamudi M, Sundar AS, Ravullapalli H, Gandham R. the effects of Dexmedetomidine on attenuation of stress response to endotracheal intubation in patients undergoing elective off-pump coronary artery bypass grafting. Ann Card Anaesth2012;15:39-43.
  • Nermin Gogus, Belgin Akan, NurtenSerger, Mustafa Baydaret al. The comparison of the effects of dexmedetomidine, fentanyl and esmolol on prevention of hemodynamic response to intubation. Braz J Anesthesiol. 2014 Sep-Oct; 64(5):314-9.
  • Debryshire DR, Fell D, Vaters M. Plasma catecholamineresponse to tracheal intubation. British Journal of Anaesthesia. 1983; 55: 855-9.
  • Bajwa SS, Kaur J, Singh G, Kulshrestha A, et al. Attenuation of pressor response and dose sparing of opioids and anaesthetics with pre-operative dexmedetomidine. Indian J Anaesth 2012; 56:123-8.




























 








 




 








 

 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.